Adar Poonawalla Thanks PM Modi, DCGI After Covishield Gets Final Approval

New Delhi: The new year couldn’t have begun on a better note for Pune-based Serum Institute Of India (SII) with Covishield getting the nod for restricted emergency use in India after the Central Drugs Standard Control Organisation (CDSCO’s)’s subject expert committee went through its data and recommended the vaccine.

A clearly exultant Adar Poonawala tweeted:

“Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India’s first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks,” Adar tweeted, thanking PM Modi, Union health minister Dr Harsh Vardhan and all other stakeholders including the Indian Council of Medical Research (ICMR), the department of biotechnology (DBT), the Drug Controller General of India (DCGI), Gavi, the international vaccine alliance, and Gates Foundation etc.

Meanwhile, soon after the Drugs Controller General of India (DCGI) gave the nod for emergency use to the vaccines of AstraZeneca-Oxford, being manufactured in India by SII and Bharat Biotech Ltd, Prime Minister Narendra Modi congratulated the nation and the scientific and healthcare community. Calling it a decisive turning point, he said it “accelerates the road to a healthier and Covid-free nation.”


“A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators,” PM Modi tweeted. “It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion,” he said.

Quelling rumours on the safety of the COVID vaccines, VG Somani, Drug Controller General of India told ANI, ” We will never approve anything if there is even the slightest safety concern. Vaccines are 110 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It (rumours of impotency) is complete nonsense.”

ALSO READ: India Gets COVID Vaccine: SII & Bharat Biotech Candidates Formally Approved


Get real time updates directly on you device, subscribe now.

Comments are closed.